Smad-mediated spliceosome assembly and alternative splicing
Project/Area Number |
25670168
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Pathological medical chemistry
|
Research Institution | Showa Pharmaceutical University |
Principal Investigator |
SAKATA Nobuo 昭和薬科大学, 薬学部, 講師 (00170598)
|
Co-Investigator(Kenkyū-buntansha) |
ITOH Susumu 昭和薬科大学, 薬学部, 教授 (70223154)
|
Project Period (FY) |
2013-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
Keywords | Alternative splicing / Smad / LUC7L3 / JMJD6 / シグナル伝達研究の新展開 / スプライソソーム |
Outline of Final Research Achievements |
We examined the possibility that Smads, TGF-β signal transducer, are involved in the alternative splicing events producing splice variants. Among Smad binding proteins identified in proteomic analysis, we analyzed the interaction of LUC7L3, spliceosome components, and Smads by the co-immunoprecipitation (Co-IP) method in detail. Otherwise, the binding of these molecules was not identified. Therefore, we tested the interaction of JMJD6 and Smads, because JMJD6 are involved in alternative splicing and interacted with LUC7L3. JMJD6 was successfully interacted with Smad2 and Smad3 by the analysis of Co-IP. Further study is needed, which will be shed light on a new scheme of Smads and alternative splicing.
|
Report
(3 results)
Research Products
(10 results)
-
-
[Journal Article] C18ORF1: A Novel Negative Regulator of TGF-β Signaling.2014
Author(s)
2. Nakano N, Maeyama K, Ikeno S, Itoh F, Togawa Y, Katsu Y, Thanh Thao, VN, Watanabe Y, Kato M & Itoh, S.
-
Journal Title
J. Biol. Chem.,
Volume: 289
Issue: 18
Pages: 12680-12680
DOI
Related Report
Peer Reviewed
-
[Journal Article] ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor initiating cell state.2013
Author(s)
Chudnovsky Y, Kim D, Zheng S, Whyte WA, Bansal M, Bray M, Gopal S, Theisen MA, Bilodeau S, Thiru P, Muffat J, Yilmaz OH, Mitalipova M, Woolard K, Lee J, Nishimura R, Sakata N, Fine HA, Carpenter AE, Silver SJ, Verhaak RGW, Califano A, Young RA, Ligon KL, Mellinghoff IK, Root DE, Sabatini DM, Hahn WC, Chheda MG
-
Journal Title
Cell Reports
Volume: 6
Issue: 2
Pages: 1-12
DOI
Related Report
Peer Reviewed
-
-
-
-
[Presentation] Negative regulation of α-fetoprotein gene transcription by TGF-β signaling with AT motif binding factor 1 (ATBF1)2014
Author(s)
Nobuo Sakata, Satoshi Kaneko, Souichi Ikeno, Yutaka Miura, Hidekazu Nakabayashi, Xue-Yuan Dong, Jin-Tang Dong, Taiki Tamaki, Naoko Nakano, Susumu Itoh
Organizer
TGF-β Meeting in Leiden 2014 “TGF-β signal transduction in human disease”
Place of Presentation
Leiden Univ. Med. Center (Leiden, NL)
Year and Date
2014-05-07 – 2014-05-10
Related Report
-
-
[Presentation] 2.TGF-β signaling cooperate with ATBF1 in AFP transcription
Author(s)
Nobuo Sakata, Satoshi Kaneko, Souichi Ikeno, Yutaka Miura, Hidekazu Nakabayashi, Xue-Yuan Dong, Jin-Tang Dong, Taiki Tamaki, Naoko Nakano, Susumu Itoh
Organizer
The 3rd International Symposium by JSPS Core-to-Core Program “Cooperative International Framework in TGF-β Family Signaling”
Place of Presentation
大和屋本店(松山市)
Related Report
-